United States· US:51267-890_8e7e5582-7a35-4ec7-85e7-b88a98d1bd23
Contrave
A bupropion and naltrexone product containing naltrexone hydrochloride; bupropion hydrochloride, registered in United States by Nalpropion Pharmaceuticals LLC. The same ATC class is registered in 12 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Bupropion and naltrexone is registered in 12 of 19 countries.
Countries holding a registration under ATC A08AA62 (bupropion and naltrexone), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 7 of them publish a price we can compare per daily dose
Bupropion and naltrexone · ATC A08AA62
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE
- Manufacturer
- Nalpropion Pharmaceuticals LLC
- Country
- United States (US)
- ATC code
- A08AA62
- ATC class
- Bupropion and naltrexone
- Defined daily dose
- 4 DE, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1151267890077 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-07)
- ndc115126789099120 TABLET, EXTENDED RELEASE in 1 BOTTLE (51267-890-99)
- ndc1151267-890-07
- ndc1151267-890-99
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bupropion and naltrexone in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMYSIMBAOrexigen Therapeutics Ireland Limited, Dublin
- CanadaCONTRAVEBAUSCH HEALTH, CANADA INC.
- PolandMysimbaOrexigen Therapeutics Ireland Limited
- FinlandMysimbaParanova Oy
- NorwayMysimbaOrexigen Therapeutics Ireland Limited (1)
- IrelandMysimba 8 mg/90 mg prolonged-release tabletsOrexigen Therapeutics Ireland Limited
- IcelandMysimbaOrexigen Therapeutics Ireland Limited
- NetherlandsMysimba 8 mg/90 mg tabletten met verlengde afgifteOrexigen Therapeutics Ireland Limited
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Mysimba
- Liechtenstein · Mysimba
- Norway · Mysimba
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d70641a3-3ad6-406f-81e3-3ea03d68e1c3 GET /v1/drugs/d70641a3-3ad6-406f-81e3-3ea03d68e1c3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "8; 90",
"substance": "NALTREXONE HYDROCHLORIDE; BUPROPION HYDROCHLORIDE",
"productndc": "51267-890",
"dosage_form": "TABLET, EXTENDED RELEASE",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1",
"application_number": "NDA200063",
"marketing_category": "NDA"
}See everything about bupropion and naltrexone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.